Glucagon-like peptide-1 Receptor Agonists (GLP-1RA) medications have emerged as a novel treatment opportunity for HS patients
Lyophilization, or freeze-drying, is a sophisticated process that removes water from the peptide under deep vacuum and frigid temperatures
The failure of behavioral interventions to produce sustained weight loss in an overwhelming majority of cases underscores the importance of identifying novel therapeutic strategies to promote and sustain reductions in food intake and body weight
GHK-Cu (Copper Peptide): Renowned for its anti-aging properties, GHK-Cu promotes collagen production, improves skin elasticity, and reduces fine lines and wrinkles
Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells
Clinical studies have documented that GLP-1 receptor agonists slow gastric emptying, particularly during initial therapy and dose titration, though this effect may attenuate somewhat over time